According to Future Market Insights' estimation, the non-invasive brain stimulation systems market will be worth USD1,200.5 million by 2022. To reach USD 2,429.3 million by 2032, the market is anticipated to grow at a CAGR of 6.6% over the forecast period (2022 to 2032).
Numerous neurological conditions, such as Parkinson's disease and tremors, have become more prevalent in recent years. This has resulted in an increase in the demand for non-invasive brain stimulation systems, which is creating the potential for businesses to generate revenue.
Given a number of benefits, such as quicker recovery time, non-invasive stimulation is favored by individuals all over the world. In light of this, non-invasive brain stimulation systems market participants see attractive opportunities in many developed and developing countries.
| Report Attribute | Details |
|---|---|
| Non-invasive Brain Stimulation System Market Historical Growth Rate (2017 to 2021) | 17.6% |
| Non-invasive Brain Stimulation System Market Value (2022) | USD 1,200.5 million |
| Non-invasive Brain Stimulation System Market Anticipated Forecast Value (2032) | USD 2,429.3 million |
| Non-invasive Brain Stimulation System Market Projected Growth Rate (2022 to 2032) | 6.6% |
The most important aspects projected to drive the non-invasive brain stimulation system market during the forecast period are the growing occurrence of neurological disorders, the upsurge of non-invasive and minimally invasive measures, the practice of casualty techniques, rushing geriatric population leading to growing brain disorders associated with age, mounting uses of the transcranial magnetic stimulation method in diagnosis, treatment of neurological disorders, satisfactory reimbursements, and innovative and scientifically advanced products presented by companies such as neuro-navigating stimulators in the global market.
Additionally, young people, these days use mobile devices extensively. As a result, people's nervous systems are affected by persistent exposure to radiation from technology, which can lead to a variety of neurological illnesses.
The Food and Drug Administration (FDA) has authorized a non-invasive brain stimulation device for the treatment of depressive disorders. Transcranial stimulation (TCS) has not been well studied, although transcranial magnetic stimulation (TMS) has been licensed for the treatment of depressive disorders.
According to the World Health Organization, the elderly population is predicted to expand more quickly in affluent countries, notably the United States of America, Japan, and numerous European nations. Treatments for depression, tinnitus, stroke, and other neurological illnesses using TMS and TCS have shown promising results. This procedure does not call for an overnight stay and is administered at specialist clinics, outpatient clinics, hospitals, and other settings. As soon as the therapy is through, patients are free to return home.
Due to increased awareness of the adverse effects of drug treatment, healthcare professionals and patient groups worldwide are increasingly choosing non-invasive brain stimulation systems over it. This element is opening up enormous commercial opportunities in the market for non-invasive brain stimulation systems.
Owing to a focus on organic growth of the non-invasive brain stimulation system market by many businesses, there are likely to be breakthroughs in non-invasive brain stimulation systems in the upcoming years. These developments will help physicians with a variety of outpatient devices and give patients new therapies in cases where conventional therapies fail.
Players in the global non-invasive brain stimulation system market are investing more in Research and Development to enhance their products' overall performance, particularly battery life. Additionally, producers of non-invasive brain stimulation systems are working to improve a number of patient-related aspects, such as reliability in IPG recharging and consistency in nocturnal device endpoint.
Many manufacturers of non-invasive brain stimulation systems are focusing on adding device-specific features such as lead configuration, parameter delivery, and implantation site. In a similar vein, they carefully choose electrode materials to minimize impedance mismatch. During the forecast period, these elements are anticipated to encourage the expansion of the non-invasive brain stimulation system market worldwide.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for non-invasive brain stimulation systems is predicted to see growth due to an increase in the number of persons suffering from neurological illnesses in key regions of the world. Neurological problems are becoming more common as the geriatric population worldwide goes up. This is driving up demand for non-invasive brain stimulation systems, which is, in turn, driving up market expansion.
Governments of many developed and developing countries provide enticing reimbursement plans for healthcare institutions. The non-invasive brain stimulation system market is growing in terms of sales based on this ground as well.
The function of the brain is investigated using functional MRI (magnetic resonance imaging) and EEG (electroencephalogram) methods. The process of stimulating the brain is also used to promote mental activity. The two techniques for brain stimulation are repeated transcranial magnetic stimulation (TMS) and transcranial current stimulation (TCS).
These two procedures, which are collectively referred to as non-invasive brain stimulation, are used to both enhance brain function and disrupt brain activity. Over the forecast period, the increasing relevance of these techniques is anticipated to encourage the growth of the worldwide non-invasive brain stimulation system market.
The industry's leading companies are concentrating on getting new non-invasive brain stimulation systems approved and put on the market in order to increase the variety of products they provide.
In addition, major industry competitors are concentrating on releasing improved versions of their non-invasive brain stimulation systems in the market. The industry is anticipated to increase as new technologies are increasingly used by hospitals.
The hazards associated with deep brain stimulation treatments, such as lead misplacement and brain haemorrhage, are one of the main reasons impeding the growth of the global non-invasive brain stimulation system market. The risk of infections brought on by IPG is expected to limit the adoption of a Non-invasive Brain Stimulation System for Parkinson's disease.
On the other hand, another major restraint concerning the non-invasive brain stimulation systems market during the forecast period is likely to be electroconvulsive therapy. It has clinically demonstrated high efficacy in treating psychotic depression, and the number of patients utilizing the therapy is extremely high.
Principal Consultant
North America is predicted to dominate the global non-invasive brain stimulation systems market during the forecast period holding nearly 34.6% market share in 2022. a sizable population with depression and other neurological and psychological disorders, the presence of cutting-edge healthcare infrastructure and technologies, the availability of integrated healthcare IT products to maintain electronic health records, investments by governments in the creation of revolutionary medical devices, the availability of skilled and trained professionals, favorable reimbursement policies, and an increase in the adoption of advanced products are all contributing to the market growth in the region.
Statistics from the Centers for Disease Control and Prevention (CDC) show that between 3.5 million and 4 million persons in the United States of America alone have depression that is resistant to therapy.
In order to enhance equipment and technology and broaden the range of uses for non-invasive brain stimulation systems, there has been an increase in partnerships and cooperation between businesses and research universities on the international market. The market participants operating in the region have several prospects as a result of this and the rising number of approvals.
The second-largest market after the United States of America, Europe has had tremendous economic growth and increased healthcare access which resulted in the region holding almost 31.7% market share.
This has created a market opportunity for producers of innovative and non-invasive devices. During the forecast period, factors such as rising psychological disorder occurrence, rising health care spending, rising government initiatives, rising Research and Development activities, rising medical tourism, and rising demand for new treatments for these disorders are anticipated to support the growth of the non-invasive brain stimulation system market in Europe.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The therapeutic potential of brain stimulation in the treatment of brain-related illnesses is currently being researched by new entrants.
For instance, LivaNova and MicroPort Scientific got FDA clearance for RegaTM pacemakers in September 2019. On the other hand, OrbiMed Advisors and KCK Groups launched an investment round of USD 74 million that NeuroPace, Inc. concluded last October.
With the help of this finance, the business will be able to quickly develop and market its FDA-approved DBS product, the NeuroPace RNS system.
Numerous companies in the non-invasive brain stimulation system market are introducing novel, transportable, user-friendly, affordable, and highly effective products. Furthermore, a lot of businesses are concentrating on commercializing their offerings.
Example:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.6% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
Product Type, Application, End-user, Region |
| Regions Covered |
North America; Latin America; The Asia Pacific; Middle East and Africa; Europe |
| Key Countries Profiled |
USA, Canada, Brazil, Argentina, Germany, United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC Countries, South Africa |
| Key Companies Profiled |
NeoSync, Inc.; Highland Instruments; MagVenture; BrainsWay; Magstim |
| Customization | Available Upon Request |
The global non-invasive brain stimulation systems market is expected to progress at a CAGR of 6.6% (2022 to 2032).
North America is expected to hold the highest share (34.6%) in the global non-invasive brain stimulation systems market.
The global non-invasive brain stimulation systems market is predicted to account for USD 2,429.3 million by 2032.
1. Executive Summary | Non-invasive Brain Stimulation System Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Transcranial Magnetic Stimulation (TMS) System 5.2. Transcranial Current Stimulation (tCS) System 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 6.1. Chronic Pain 6.2. Tremor 6.3. Depression 6.4. Epilepsy 6.5. Parkinson's Disease 6.6. Others 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 7.1. Hospital 7.2. Ambulatory Surgical Centers 7.3. Clinics 7.4. Specialty Care Value (US$ Million) 7.5. Others 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Asia Pacific 8.5. Japan 8.6. Middle East and Africa 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. Western Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. Japan Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. NeoSync, Inc. 17.2. Highland Instruments 17.3. Mayfield Brain and Spine 17.4. Boston Scientific Corporation 17.5. Abbott Laboratories 17.6. Medtronic plc 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Non-invasive Brain Stimulation System Market
